Ke LD - Search Results

1

A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes.

Ke LD, Fueyo J, Chen X, Steck PA, Shi YX, Im SA, Yung WK. Ke LD, et al. Int J Oncol. 1998 Jun;12(6):1391-6. doi: 10.3892/ijo.12.6.1391. Int J Oncol. 1998. PMID: 9592205

2

VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells.

Ke LD, Shi YX, Yung WK. Ke LD, et al. Cancer Res. 2002 Mar 15;62(6):1854-61. Cancer Res. 2002. PMID: 11912165

3

The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines.

Ke LD, Shi YX, Im SA, Chen X, Yung WK. Ke LD, et al. Clin Cancer Res. 2000 Jun;6(6):2562-72. Clin Cancer Res. 2000. PMID: 10873113

4

MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.

Koul D, Shen R, Garyali A, Ke LD, Liu TJ, Yung WK. Koul D, et al. Among authors: ke ld. Int J Oncol. 2002 Sep;21(3):469-75. Int J Oncol. 2002. PMID: 12168088

5

Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.

Im SA, Gomez-Manzano C, Fueyo J, Liu TJ, Ke LD, Kim JS, Lee HY, Steck PA, Kyritsis AP, Yung WK. Im SA, et al. Among authors: ke ld. Cancer Res. 1999 Feb 15;59(4):895-900. Cancer Res. 1999. PMID: 10029081

6

A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards.

Ke LD, Chen Z, Yung WK. Ke LD, et al. Mol Cell Probes. 2000 Apr;14(2):127-35. doi: 10.1006/mcpr.2000.0288. Mol Cell Probes. 2000. PMID: 10799275

7

Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines.

Ke LD, Adler-Storthz K, Mitchell MF, Clayman GL, Chen Z. Ke LD, et al. Oral Oncol. 1999 Jul;35(4):415-20. doi: 10.1016/s1368-8375(99)00015-9. Oral Oncol. 1999. PMID: 10645408

8

Differential expression of epidermal growth factor receptor in human head and neck cancers.

Ke LD, Adler-Storthz K, Clayman GL, Yung AW, Chen Z. Ke LD, et al. Head Neck. 1998 Jul;20(4):320-7. doi: 10.1002/(sici)1097-0347(199807)20:4<320::aid-hed7>3.0.co;2-0. Head Neck. 1998. PMID: 9588705

9

Correlation of cisplatin sensitivity with differential alteration of EGFR expression in head and neck cancer cells.

Chen Z, Ke LD, Yuan XH, Adler-Storthz K. Chen Z, et al. Among authors: ke ld. Anticancer Res. 2000 Mar-Apr;20(2A):899-902. Anticancer Res. 2000. PMID: 10810374

10

Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.

Shain SA, Sarić T, Ke LD, Nannen D, Yoas S. Shain SA, et al. Among authors: ke ld. Cell Growth Differ. 1996 May;7(5):573-86. Cell Growth Differ. 1996. PMID: 8732667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters